CIPRO vs. MAXIDEX / CILOXAN
A
Comparison of CIPRODEX(an investigational drug, Ciprofloxacin 0.3%,
Dexamethasone 0.1%) Ophthalmic Suspension, vs. CILOXAN®
(ciprofloxacin 0.3%) Ophthalmic Solution, MAXIDEX® (Dexamethasone
0.1%) Ophthalmic Suspension and CIPRODEX Vehicle for Treatment of
Bacterial Blepharitis
MOXIFLOXACIN vs. Gatifloxacin
An
Open-Label, Multi-site, Two-arm Pharmacokinetic Study of Aqueous
Humor Concentration of Moxifloxacin After Topical Ocular
Administration with Moxifloxacin Ophthalmic Solution 0.5% in
Patients Undergoing Cataract Surgery.
Bacterial Blepharitis
A
Comparison of CIPRODEX (Ciprofloxacin 0.3%, Dexamethasone 0.1%)
Ophthalmic Suspension, CILOXAN (Ciprofloxacin 0.3%) Ophthalmic
Solution, and MAXIDEX (Dexamethasone 0.1%) Ophthalmic Suspension vs.
CIPRODEX Vehicle for the Treatment of Chronic Bacterial Blepharitis.
MOXI. Vs. NON-PRES. VEHICLE
A
Clinical Evaluation of the Safety and Efficacy of MOXIFLOXACIN
Ophthalmic Solution 0.5% Vs. Non-Preserved Vehicle in the Treatment
of Bacterial Conjunctivitis.
MOXI vs. MOXI VEHICLE Bacterial
Conjunctivitis
Safety and
Efficacy of MOXIFLOXAVIN Ophthalmic solution Vs. MOXIFLOXACIN
Vehicle in the Treatment of Bacterial Conjunctivitis Using BID
Dosing.
GATIFLOX.
vs. OFLOXACIN
A Phase
III Multi-Centered, Randomized, Double-Masked, Parallel Study to
Compare the Safety and Efficacy of GATIFLOXACIN 0.3% Ophthalmic
Solution with that of OFLOXACIN 0.3% Ophthalmic Solution in the
Treatment of Acute Bacterial Conjunctivitis.
Reduction
of Surface Flora Study: CIPROFLOXACIN 0.3% Vs. OFLOXACIN 0.3%
in the Reduction of Conjunctival Flora in Human Subjects
Phase 2
Study of MOXIFLOXACIN vs. OFLOXACIN in the Treatment of Acute
Bacterial Conjunctivitis.
A Comparison of
CIPROFLOXACIN Ophthalmic Ointment 0.3% Vs. CIPROFLOXACIN Ophthalmic
Solution 0.3% (CILOXAN) monotherapy in the Treatment of Acute
Bacterial Conjunctivitis.
Corneal
Ulcer
Study
Evaluation of
CIPROFLOXACIN Ophthalmic Ointment 0.3% in Treating Bacterial Corneal
Ulcers.
Corneal
Ulcer
Study
A Clinical Evaluation of
the Efficacy and Safety of CIPROFLOXACIN Ophthalmic Solution in the
Treating Bacterial Corneal Ulcers
Corneal
Ulcer
Study
Double-Masked Comparison
of CILOXAN to Fortified TOBRAMYCIN/CEFAZOLIN for Treating Bacterial
Corneal Ulcers.
Bacterial
Conjunctivitis Study
Clinical and
Microbiological Study Comparing CIPROFLOXACIN Ophthalmic Solution to
TOBREX for the Treatment of Conjunctivitis.
A STUDY TO EVALUATE THE CLINICAL
AND MICROBIAL EFFICACY AND SAFETY OF 1.0% ISV-401 COMPARED TO 0.3%
TOBRAMYCIN OPHTHALMIC SOLUTION IN THE TREATMENT OF BACTERIAL
CONJUNCITIVITIS
REBAMIPIDE
Rebamipide Ophthalmic
Suspension in the Treatment of Dry Eye: A Multicenter, Phase 3,
Randomized, Double-masked, Placebo-Controlled, Parallel-Group, 52
Week Study.
PK/MOXIFLOXACIN
An Open-Label, Multiple
Dose, Pharmacokinetic Study of Moxifloxacin and Gatifloxacin
Concentrations in the Cornea Following Topical Ocular
Administration with either VIGAMOX or Zymar in Patients Undergoing
Penetrating Keratoplasty.
T-DEX vs.
T-DEX PRES. FREE
A
Double-Masked, Parallel-Design, Randomized, Single Dose,
Bioequivalence Study of TOBRADEX BAC-Free and TOBRADEX Ophthalmic
Formulations.
MOXIFLOXACIN
Effectiveness of Topical Moxifloxacin 0.5% (VIGAMOX™) in the
Reduction of Bacterial Flora on the Conjunctiva of the Human Eye.
